Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Myelodysplastic Syndromes 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia, Myeloid, Acute 11Multiple Myeloma 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Lymphoma, Non-Hodgkin 6Lymphoma 6Myeloproliferative Disorders 5Hodgkin Disease 5Leukemia, Myelomonocytic, Juvenile 4Leukemia 4Precancerous Conditions 3Neoplasms, Plasma Cell 3Lymphoma, Mantle-Cell 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Biphenotypic, Acute 3Hematologic Neoplasms 3Burkitt Lymphoma 3Anemia, Aplastic 3Waldenstrom Macroglobulinemia 2Smoldering Multiple Myeloma 2Recurrence 2Primary Myelofibrosis 2Preleukemia 2Neoplasms by Histologic Type 2Neoplasms 2Lymphoproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

zilucoplan 1thymoglobulin 1ravulizumab 1prednylidene 1inebilizumab 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Robotic Surgical Procedures 1Rituximab 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Etoposide 1Cytarabine 1Carmustine 1Blood Specimen Collection 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Myasthenia Gravis × Melphalan × Clear all
NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
53 enrolled
CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡